Présentations orales

Estimation of human papillomavirus (HPV) transmissibility: insights from mathematical modeling EUROGIN 2013 HPV AT A CROSSROADS - 30 YEARS OF RESEARCH AND PRACTICE. Florence, Italie. 3-6 novembre, 2013. Brisson M
HPV vaccination in developing countries: assessing the value of vaccines across the world EUROGIN 2013 HPV AT A CROSSROADS - 30 YEARS OF RESEARCH AND PRACTICE. Florence, Italie, 3-6 novembre, 2013. Jit M, Brisson M, Portnoy A, Hutubessy R
2 vs. 3 doses Schedule - High income countries (HIC) EUROGIN 2013 HPV AT A CROSSROADS - 30 YEARS OF RESEARCH AND PRACTICE. Florence, Italie. 3-6 novembre, 2013. Brisson M
Inequalities in cervical cancer: role of vaccine herd immunity in protecting women with low screening participation EUROGIN 2013 HPV AT A CROSSROADS - 30 YEARS OF RESEARCH AND PRACTICE. Florence, Italie. 3-6 novembre, 2013. Malagon T, Drolet M, Boily MC, Laprise JF, Brisson M
Cross-protection and alternating doses schedules EUROGIN 2013 HPV AT A CROSSROADS - 30 YEARS OF RESEARCH AND PRACTICE. Florence, Italie. 3-6 novembre, 2013. Brisson M
Comparing the cost-effectiveness of the bivalent, quadrivalent and nonavalent HPV vaccines: a model-based analysis 28th International Papillomavirus Conference. San Juan, Puerto Rico. 30 novembre- 6 décembre, 2012. Brisson M, Van de Velde N, Laprise JF, Drolet M, Boily MC
Incremental cost-effectiveness of vaccinating boys against human papillomavirus (HPV) in Canada: a model-based analysis 28th International Papillomavirus Conference. San Juan, Puerto Rico. 30 novembre- 6 décembre, 2012. Laprise JF, Van de Velde N, Boily MC, Drolet M, Brisson M
Examining the potential population-level impact of maldistribution of HPV vaccine by future cervical screening participation 28th International Papillomavirus Conference. San Juan, Puerto Rico. 30 novembre- 6 décembre, 2012. Malagon T, Van de Velde N, Boily MC, Laprise JF, Drolet M, Brisson M
Vaccinating girls with the bivalent and boys with the quadrivalent vaccine: Is it a good idea? 28th International Papillomavirus Conference. San Juan, Puerto Rico. 30 novembre- 6 décembre, 2012. Drolet M, Van de Velde N, Boily MC, Brisson M
Prevalence of Heterosexual Anal Intercourse Among sexually Active Youth: A Systematic Review and Meta-analysis 28th International Papillomavirus Conference. San Juan, Puerto Rico. 30 novembre- 6 décembre, 2012. Boily MC, Owen B, Baggaley RF, Butler AR, Pickles M, Brisson M, Drolet M
Estimating the Long-Term Impact and Cost-Effectiveness of Prophylactic Human Papillomavirus Vaccination in Medically Underserved, Low Income Populations in the United States 28th International Papillomavirus Conference. San Juan, Puerto Rico. 30 novembre- 6 décembre, 2012. Ekwueme DU, Geng Y, Chesson HW, Cooney D, Saraiya M, Brisson M, Franco EL, Li C, Benard V, Royalty J, Watson M
Can we have two instead of three? –Mathematical modelling effects of two dose HPV vaccine schedules 28th International Papillomavirus Conference. San Juan, Puerto Rico. 30 novembre- 6 décembre, 2012. Choi YH, Brisson M, Boily MC, Van de Velde N, Laprise JF, Jit M
What’s it worth? Cost-Effectiveness of Vaccinating Males Against HPV 28th International Papillomavirus Conference. San Juan, Puerto Rico. 30 novembre- 6 décembre, 2012. Brisson M
Understanding the public health consequences of the epidemiological interaction between HIV and HPV infections 28th International Papillomavirus Conference. San Juan, Puerto Rico. 30 novembre - 6 décembre, 2012. Boily MC, Looker KJ, Brisson M, Drolet M
Systematic review of oral HPV infection risk factors 28th International Papillomavirus Conference. San Juan, Puerto Rico. 30 novembre - 6 décembre, 2012. Lemieux-Mellouki P, Drolet M, Boily MC, Brisson M
Serotype replacement : Should we be worried? Congrès EUROGIN 2012. Prague, République Tchèque. 8-11 juillet 2012. Boily MC, Van de Velde N, Brisson M
Cross-protection: How do we interpret trial data, and how important is it at a population-level? Congrès EUROGIN 2012. Prague, République Tchèque. 8-11 juillet 2012. Malagòn T, Van de Velde N, Drolet M, Laprise JF, Boily MC, Brisson M
The Impact of vaccination on HPV-related diseases in men & women: A Model-based analysis Congrès EUROGIN 2012. Prague, République Tchèque. 8-11 juillet 2012. Brisson M, Van de Velde N, Drolet M, Laprise JF, Malagòn T, Boily MC
Cost-effectiveness issues- are they questionable? Congrès EUROGIN 2012. Prague, République Tchèque. 8-11 juillet 2012. Brisson M
Population-level effectiveness and cost-effectiveness of HPV vaccination strategies: A comparative model-based analysis Center for Disease Control. Atlanta, Géorgie, États-Unis. 2 février 2012. Brisson M
Sociodemographic inequalities in the main risk factors for HPV-related diseases 27th International papillomavirus conference. Berlin, Allemagne. 17- 23 septembre, 2011. Drolet M, Brisson M
HPV– vaccine programs: when can we know we are reaching objectives? 27th International papillomavirus conference. Berlin, Allemagne. 17- 23 septembre, 2011. Boily MC, Van de Velde N, Drolet M, Laprise JF, Malagon T, Brisson M
Modeling the effectiveness of the bivalent, quadrivalent and nonavalent vaccines 27th International papillomavirus conference. Berlin, Allemagne. 17- 23 septembre, 2011. Van de Velde N, Malagon T, Drolet M, Laprise JF, Boily MC, Brisson M
Role of mathematical models to monitor and evaluate HPV vaccination 27th International papillomavirus conference. Berlin, Allemagne. 17- 23 septembre, 2011. Boily MC, Brisson M
Impact of cross-protection: from clinical trial results to population-level effectiveness 27th International papillomavirus conference. Berlin, Allemagne. 17- 23 septembre, 2011. Brisson M, Van de Velde N, Malagon T, Drolet M, Laprise JF, Boily MC
HPV transmissibility and HPV-status at partnership separation: a model-based analysis 27th International papillomavirus conference. Berlin, Allemagne. 17- 23 septembre, 2011. Laprise JF, Van de Velde N, Boily MC, Drolet M, Brisson M
Issues in comparing and interpreting clinical trial measures of cross-protection 27th International papillomavirus conference. Berlin, Allemagne. 17- 23 septembre, 2011. Malagon T, Drolet M, Van de Velde N, Boily MC, Brisson M
Vaccination des garçons contre le Virus du papillome humain (VPH): état des connaissances Conférence en santé publique. Université Laval, Québec, Canada. 11 septembre 2011. Brisson M
Potential impact of HPV vaccination on health disparities EUROGIN 2011 Congress. Lisbon, Portugal. 8- 11 mai, 2011. Brisson M, Van de Velde N, Boily MC
Examining the potential impact of HPV vaccination on health disparities using mathematical models SIMID workshop. Antwerp, Belgique. 31 janvier- 1 février, 2011. Brisson M, Van de Velde N, Boily MC
Understanding the psychosocial burden of genital warts in Canada: A prospective 6-month study 26th International papillomavirus conference. Montréal, Canada. 3- 4 juillet, 2010. Drolet M, Brisson M, Maunsell E, Ferenczy A, Franco E, Coutlée F, Palefsky J, Mansi J
Impact of disparities in HPV vaccine coverage on population-level effectiveness 26th International papillomavirus conference. Montréal, Canada. 3-8 juillet, 2010 Brisson M, Van de Velde N, Boily MC
Predictors of high anxiety following an abnormal cervical cytology result 26th International papillomavirus conference. Montréal, Canada. 3- 4 juillet, 2010. Drolet M, Brisson M, Maunsell E, Ferenczy A, Franco E, Coutlée F, Palefsky J, Mansi J
Smaller population-level impact of HPV vaccines on HPV-16/18 compared to HPV-6/11: what are the implications 26th International papillomavirus conference. Montréal, Canada. 3-8 juillet, 2010. Boily MC, Van de Velde N, Brisson M
Smaller population-level impact of HPV vaccines on HPV-16/18 compared to HPV-6/11: what are the implications 26th International papillomavirus conference. Montréal, Canada. 3- 4 juillet, 2010. Boily MC, Van de Velde N, Brisson M
Modeling the incremental impact of vaccinating boys against HPV 26th International papillomavirus conference. Montréal, Canada. 3-8 juillet, 2010. Brisson M, Van de Velde N, Boily MC
Disparities in Gardasil uptake in Manitoba, Canada prior to the implementation of an immunization program 26th International papillomavirus conference. Montréal, Canada. 3- 4 juillet, 2010. Kliewer E, Demers A, Lambert P, Brisson M
Impact of structural uncertainty on predictions of HPV vaccine effectiveness: A comparative model-based analysis SIMID workshop. Antwerp, Belgique. 12- 14 avril, 2010. Brisson M, Van de Velde N, Boily MC
Cost-effectiveness of 1- and 2-dose varicella vaccination SIMID workshop. Antwerp, Belgique. 12- 14 avril, 2010. Brisson M, Melkonyan G, Drolet M, De Serres G, Thibeault R, De Wals P
The ABC of Cost-Effectiveness and Economic Evaluation of HPV Vaccination Toronto Health Economics and Technology Assessment Collaborative. Université de Toronto, Toronto, Canada. 12 mars, 2010. Brisson M
Loss of quality of life associated with genital warts: a prospective 6-month study EUROGIN 2010 Congress. Monte Carlo, Monaco. 17- 20 février, 2010. Drolet M, Brisson M, Maunsell , Ferenczy A, Franco EL, Ratnam S, Coutlée F, Palefsky JM, Blanchette C, Mansi JA
Modelling the impact of vaccinating males against HPV infection. EUROGIN 2010 Congress Monte Carlo, Monaco. 17- 20 février, 2010. Brisson M, Van de Velde N, Boily MC
Modelling the herd-immunity impact of female vaccination on HPV infection in males EUROGIN 2010 Congress. Monte Carlo, Monaco. 17- 20 février, 2010. Brisson M, Van de Velde N, Boily MC
Quality of life lost following an abnormal cervical cytology result: a prospective 3-month study EUROGIN 2010 Congress. Monte Carlo, Monaco. 17- 20 février, 2010. Brisson M, Drolet M, Maunsell , Ferenczy A, Franco EL, Ratnam S, Coutlée F, Palefsky JM, Blanchette C, Mansi JA
Quality of life EUROGIN 2010 Congress. Monte Carlo, Monaco. 17- 20 février, 2010. Brisson M
The Cost of Treating Anogenital Warts in Manitoba, Canada 24th International papillomavirus conference. Beijing, Chine. 2- 10 novembre, 2007. Butler JRG, Kliewer EV, Demers AA, Musto G, Lotocki R, Elliott L, Brisson M
Dynamic modeling of HPV vaccine effectiveness: Impact of uncertainty in biological and behavioural parameter assumptions and model structure 18th ISSTDR Conference. London, UK. 28 juin- 1 juillet, 2009. Van de Velde N, Brisson M, Boily MC
Dynamic modeling of HPV vaccine effectiveness: Impact of partnership formation 25th International papillomavirus conference. Malmo, Suède. 8-14 mai, 2009. Van de Velde N, Brisson M, Boily MC
Dynamic modeling of HPV vaccine effectiveness: Impact of structure 25th International papillomavirus conference. Malmo, Suède. 8- 14 mai, 2009. Van de Velde N, Brisson M, Boily MC
Modeling the impact of a second dose of varicella vaccination on varicella and herpes zoster Global Virology Foundation conference. Annecy, France. 18 avril 2009. Brisson M
Effects of vaccines - Chickenpox vaccination on chickenpox and herpes zoster Global Virology Foundation conference. Annecy, France. 18 mai, 2009. Brisson M
QALY-lost during the first 90 days after the onset of Herpes Zoster 8th Canadian Immunization Conference. Toronto, Canada. 30 novembre- 3 décembre, 2008. Drolet M, Brisson M, Johnson RW, Levin MJ, Oxman MN, Schmader KE, Patrick DM, Mansi JA
Potential Cost-effectiveness of vaccination against Herpes Zoster and PHN in Canada 7th Canadian Immunization Conference. Winnipeg, Canada. 3-6 décembre, 2006. Brisson M, Pellissier JM, Quach C, De Wals P
The Health and Economic Burden of HPV Infection, Dysplasia and Cervical Cancer in Canada 7th Canadian Immunization Conference. Winnipeg, Canada. 3-6 décembre, 2006. Brisson M, Van de Velde N, Boily MC, De Wals P
Measuring the Pain and Severity Associated with the Prodromal Phase of Herpes Zoster (HZ) in Canada: A Prospective Community Based Study 7th Canadian Immunization Conference. Winnipeg, Canada. 3-6 décembre, 2006. risson M, Johnson RW, Levin MJ, Oxman MN, Schmader KE, Patrick DM, Koch C, Senecal M, Mansi JA
Measuring the Pain and Severity Associated with the Prodromal Phase of Herpes Zoster (HZ) in Canada: A Prospective Community Based Study 13th Annual Meeting of the International Herpes Management Forum (IHMF). Prague, République Tchèque. 27-29 octobre, 2006. Brisson M, Johnson RW, Levin MJ, Oxman MN, Schmader KE, Patrick DM, Koch C, Senecal M, Mansi JA
Evaluation of the cost-effectiveness in the U.S. of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults National Foundation for Infectious Diseases Vaccine Research 9th Annual Conference. Baltimore, Maryland. 8-10 mai, 2006 Pellissier JM, Brisson M, Levin MJ
Potential Cost-effectiveness of vaccination against Herpes Zoster and PHN in Canada 44th Annual Meeting of the Infectious Diseases Society of America (IDSA). Toronto, Canada. 12-15 octobre, 2006. Brisson M, Pellissier JM, Quach C, De Wals P
Se connecter

Administration du site

Cette section est utilisée par les administrateurs du site seulement. Vous devez posséder un nom d'usager ainsi qu'un mot de passe pour y accéder.